EICHORCondition: Graft-versus-host Disease · Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
The aim of this study is to demonstrate that in subjects with moderate to severe chronic graft-versus-host disease in the third line and beyond, the use of rosuvastatin compared to the protocol chosen by the researchers can significantly improve the objective response rate of subjects at week 24.
This description comes directly from the study's public registry record.
He Huang, Doctor · 13605714822 · hehuangyu@126.com
Always discuss trial participation with your own doctor first.
| The First Affiliated Hospital of USTC Anhui Provincial Hospital | Hefei, Anhui, China | Not Yet Recruiting |
| Peking University First Hospital | Beijing, Beijing Municipality, China | Not Yet Recruiting |
| Peking University People's Hospital | Beijing, Beijing Municipality, China | Not Yet Recruiting |
| The Southwest Hospital of AMU | Chongqing, Chongqing Municipality, China | Not Yet Recruiting |
| Fujian Medical University Union Hospital | Fuzhou, Fujian, China | Not Yet Recruiting |
| The First Affiliated Hospital of Xiamen University | Xiamen, Fujian, China | Not Yet Recruiting |
| The First Hospital of Lanzhou University | Lanzhou, Gansu, China | Not Yet Recruiting |
| The 904 Hospital of the Joint Service Support Force of the People's Liberation Army of China | Lanzhou, Gansu, China | Not Yet Recruiting |
| Guangzhou First People's Hospital The First People's Hospital Affiliated to Guangzhou Medical University | Guangzhou, Guangdong, China | Not Yet Recruiting |
| Nanfang Hospital | Guangzhou, Guangdong, China | Not Yet Recruiting |
| The First Affiliated Hospital of Guangxi Medical University | Nanning, Guangxi, China | Not Yet Recruiting |
| The Affiliated Hospital of Guizhou Medical University | Guiyang, Guizhou, China | Not Yet Recruiting |
+ 29 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06682169